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Hyperbaric oxygen (HBO2)e x p o s u r ea ﬀects both oxidative and antioxidant systems. This eﬀect is positively correlated with the
exposuretimeanddurationofthetreatment.ThepresentstudyaimsenlighteningtherelationofHBO2 withoxidative/antioxidant
systems when administered in a prolonged and repetitive manner in brain tissues of rats. Sixty rats were divided into 6 study
(n = 8f o re a c h )a n d1c o n t r o l( n = 12) group. Rats in the study groups were daily exposed 90-min HBO2 sessions at 2.8ATA
for 5, 10, 15, 20, 30 and 40 days. One day after the last session, animals were sacriﬁced; their whole brain tissue was harvested
and dissected into three diﬀerent regions as the outer grey matter (cortex), the inner white matter and cerebellum. Levels of lipid
peroxidation and protein oxidation and activities of superoxide dismutase and glutathione peroxidase were measured in these
tissues. Malondialdehyde, carbonylated protein and glutathione peroxidase levels were found to be insigniﬁcantly increased at
diﬀerent time-points in the cerebral cortex, inner white matter and cerebellum, respectively. These comparable results provide
evidence for the safety of HBO treatments and/or successful adaptive mechanisms at least in the brain tissue of rats, even when
administered for longer periods.
1.Introduction
Hyperbaric oxygen (HBO2) therapy (HBOT) is the medical
use of oxygen at a level higher than atmospheric pressure
[1]. Its principle depends, at least in part, on the vital nature
of oxygen needed to provide energy and support cellular
respiration. It is obvious that decreased delivery of oxygen
can aﬀect cell survival. Several diseases or injuries can de-
creasethebody’sabilitytotransportoxygentothetissues,in-
crease the tissue demands for oxygen, and may elongate the
distance that the oxygen must travel from the capillary to
reach the cell [2]. Depending on this fact, HBOT has been
successfully used in treating various pathological conditions
underlying an inﬂammatory background [3], such as colitis
[4], cystitis [5], pancreatitis [6], or sepsis [7, 8].
From another point of view, due to the large amounts
of pure oxygen breathed, HBO2 treatments were also hold
responsible for the potential of oxygen toxicity [9, 10]. In
the medical literature, noticeable evidence has been accu-
mulated proving that even a single HBO2 exposure can
trigger oxidative stress [11–13]. Free radical generation, sub-
sequently leading to oxidative stress, has long been known as
at least one of the reasons of central nervous system (CNS)
oxygen toxicity [14].
Apartfromtheformerstudiesperformedatsupranormal
pressure/duration ranges of HBO2 exposure, that is, higher
than 3 atmospheres and longer than 2 hours, in order to test
some protective agents against CNS oxygen toxicity [15–17],
more recent works evidenced that, even within its approved
therapeuticlimits,HBO2 treatmentenhancesoxidativestress
markers in brain tissue [18–20]. Since HBO2 applications
have been mostly performed over a longer period with
repetitive exposures [1], it is of particular importance to
test its interactions with oxidative/antioxidant systems in2 The Scientiﬁc World Journal
Table 1: Experimental schedule of the entire study.
n Mon. Tue. Wed. Thu. Fri. Sat. (sacriﬁcing) Sun.
Week 1 48 HBO2 +1 2C H B O 2 HBO2 HBO2 HBO2 HBO2 8H B O 2 +2C
N/A
Week 2 40 HBO2 +1 0C H B O 2 HBO2 HBO2 HBO2 HBO2 8H B O 2 +2C
Week 3 32 HBO2 +8C H B O 2 HBO2 HBO2 HBO2 HBO2 8H B O 2 +2C
Week 4 24 HBO2 +6C H B O 2 HBO2 HBO2 HBO2 HBO2 8H B O 2 +2C
Week 5 16 HBO2 +4C H B O 2 HBO2 HBO2 HBO2 HBO2 N/A
Week 6 16 HBO2 +4C H B O 2 HBO2 HBO2 HBO2 HBO2 8H B O 2 +2C
Week 7 8 HBO2 +2C H B O 2 HBO2 HBO2 HBO2 HBO2 N/A
Week 8 8 HBO2 +2C H B O 2 HBO2 HBO2 HBO2 HBO2 8H B O 2 +2C
All of the HBO2 administrations and animal sacriﬁcing were performed at 10.00AM (C: control n: animal count).
experimental sets simulating its clinical use, for example,
lower than 3atm and 2h.
Inarecentstudy,wedemonstratedariseinlipidandpro-
tein oxidation products in the lung tissues of rats accom-
panied by increased antioxidant enzyme activities when
HBOT was continued for more than 20 sessions [21]. Apart
from the lung as being the entering site of hyperoxic injuries,
the CNS is mainly accepted as another important target for
oxygen exposure in toxic amounts [22]. Depending on this
fact, the present study was conducted in order to enlighten
the eﬀects of consecutive HBO2 exposures from 5 up to 40
daily sessions on oxidative stress and antioxidant defense
markers of rat’s diﬀerent brain regions.
2.MaterialsandMethods
2.1. Study Design. Our institutional Experimentation and
Ethics Committee approved the experimental procedures of
the study. A total of 60 adult male Sprague-Dawley rats bred
inGulhaneMilitaryMedicalAcademyResearchandProgress
Center were used. The rats were 12 weeks old and weighed
200–250g at the beginning of the experiment. Housing was
at 22–24◦C with light from 08.00AM to 08.00PM and free
access to water. All animals were fed standard commercial rat
chow during the experiment.
Rats were divided into 6 study groups (n = 8f o re a c h )
which were exposed to HBO2 f o r1 ,2 ,3 ,4 ,6 ,a n d8w e e k s .
Weekly HBO2 administrations were set as 5 daily consecutive
exposures followed by 2-day intervals. All animals in the
study groups were sacriﬁced one day after their ﬁnal HBO2
treatment in order to avoid possible interference of the acute
postexposure phase. Separate control groups consisted of
6–8 animals for each time points were forbidden by our
institutional Ethics Committee (issue 08/75K). Thus, 2 con-
trolanimalsweresacriﬁcedatthesametimepointswitheach
of the 6 study groups (n = 12 in total for control group) in
order to evaluate possible eﬀects of aging. Details of the ex-
perimental schedule are to be seen in Table 1.
2.2. HBO2 Exposures. An animal hyperbaric chamber (made
in Etimesgut Military Equipment Factory, Ankara, Turkey)
was used for the HBO2 administrations. The HBO2 sessions
were set as 2.8atm pressure for 90min in all study groups.
Compression and decompression of the chamber was com-
pleted gradually in 5–10min; continuous 100% O2 ventila-
tion at a rate of 3-4L/min was maintained throughout the
90min exposure periods in the chamber. All administrations
were started at the same hour in the morning (10.00AM) to
equalize possible eﬀects of the circadian rhythm [23].
2.3. Tissue Preparation. For tissue sampling, animals were
anesthetized (i.p. ketamine + xylazine, 85 + 12.5mg/kg) 24h
after the last HBO session. Their skulls were opened, and
their whole brain tissues were harvested. Then the brain tis-
sues were immediately dissected into its three diﬀerent re-
gions as the outer grey matter (cerebral cortex), the inner
white matter, and the cerebellum, put into tubes, and frozen
with liquid nitrogen. The frozen tissues were homogenized
in phosphate buﬀer (pH 7.4) by means of a homogenizer
(Retsch Mixer Mill MM 400: D¨ usseldorf, Germany) and cen-
trifuged (Hermle Z323K: Gosheim, Germany) at 2,500rpm
for 10min. The supernatants were divided into two to three
parts, put in separate tubes, and stored at −80◦C until assay.
2.4. Biochemical Analysis. The supernatants of the tissue
homogenates were used for the entire assays. Lipid peroxida-
tion levels were measured using the thiobarbituric acid reac-
tion by the method of Ohkawa et al. [24]. This method was
used to obtain a spectrophotometric (Helios epsilon, USA)
measurement of the color produced during the reaction to
thiobarbituric acid with malondialdehyde (MDA) at 535nm.
Tissue protein carbonyl content (PCC) was determined with
the method described by Levine et al. [25]. Final calculated
MDA and PCC levels were expressed as millimoles per gram
protein. The activity of the antioxidant enzyme superoxide
dismutase (SOD) was assayed using the nitroblue tetra-
zolium (NBT) method of Sun et al. [26]. Brieﬂy, NBT was
reduced to blue formazan by the superoxide anion radical,
which has strong absorbance at 560nm. One unit (U) of
SODisdeﬁnedastheamountofproteinthatinhibitstherate
of NBT reduction by 50%. Glutathione peroxidase (GSH-
Px) activity was measured using the method described by
Paglia and Valentine [27]. The estimated SOD and GSH-Px
activitieswereexpressedasunitspergramprotein.Finally,in
order to standardize the measured data, the protein contentThe Scientiﬁc World Journal 3
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Figure 1: Oxidation products and antioxidant enzymes in brain cortex tissue. C: control group; numbers on the x-axis stand for the HBO2
session number of the groups. One-way ANOVA: 1P = 0.016; 2P = 0.005; 3P<0.001. Bonferroni:
∗P = 0.047 versus 40-session group;
∗∗P = 0.013 versus 15-, and P = 0.012 versus 30-session groups;
∗∗∗P < 0.001 versus 10-, P = 0.001 versus 15-, and P = 0.043 versus
20-session HBO2 groups. Note that no signiﬁcant changes for any measured parameters were recorded in comparison with the control
values.
of the hemolysates was measured according to the method of
Lowryetal.[28]withbovineserumalbuminasthestandard.
2.5. Statistical Analyses. Normality analyses were performed
by using the Kolmogorov-Smirnov and Shapiro-Wilk tests,
and the entire data of the study was found to be normally
distributed. Thus, parametric statistics were used for the
evaluationoftheresults;thatis,iftheonewayanalysisofvari-
ance (ANOVA) indicated intergroup signiﬁcance, the post
hoc Bonferroni test was performed for group-to-group com-
parisons. P values less than 0.05 were considered signiﬁcant.
All analyses were performed using the SPSS software
(Version 15.0; SPSS, Chicago, IL, USA).
3. Results
According to general observations, symptoms for barotrau-
mas, hyperoxic convulsions, and weight gain or loss, no un-
expected or adverse eﬀects were observed throughout the ex-
perimental period. All animals survived the study period
untilbeingsacriﬁcedfortissuesamplingandanalyzing.None
of the measured parameters revealed any signiﬁcant change
when compared with the control values (P>0.05 for all
parameters at all measure points versus their related control
group). The entire data of the study is presented in box-plot
graphics showing the median, minimum, maximum values,
and the quartiles for each group.
3.1.BrainCortexTissue(GreyMatter). Incortextissue,MDA
valuestendedtoincreasewithlongerHBO2 exposureperiods
of 20, 30, and 40 sessions, but this slight increase was esti-
matedtobestatisticallyinsigniﬁcant.Noevidenceforprotein
oxidation (PCC) and no evident changes in the antioxidant
enzymes SOD and GSH-Px activities were recorded in brain
cortex specimens in comparison with control levels (P>
0.05). Group-to-group comparisons revealed signiﬁcantly
increased MDA values in 40-session HBO2 group versus the
15-session group, signiﬁcantly decreased SOD activities in
the15-and30-sessiongroupsversusthe5-sessiongroup,and
signiﬁcantly decreased GSH-Px activities in the 10-, 15-, and
20-sessiongroupsversusthe5-sessionHBO2 exposuregroup
(P<0.05; Figure 1).4 The Scientiﬁc World Journal
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Figure 2: Oxidation products and antioxidant enzymes measured in the white matter of the brain. C: control group; numbers on the x-axis
stand for the HBO2 session number of the groups. One-way ANOVA: 1P = 0.001. Bonferroni:
∗P = 0.005 and P = 0.006 versus 20-, and
30-session HBO2 groups, respectively. No signiﬁcant variations compared with the control group were recorded.
3.2. Brain Inner Material (White Matter). The white matter
of the brain presented no decisive change for MDA values or
SODandGSH-Pxactivitiescomparedtocontrols(P>0.05).
Only a light insigniﬁcant increase of PCC with just 5 HBO
exposures was to be seen. Apart from the control group,
the 20- and 30-times HBO2 exposed groups presented sig-
niﬁcantly lower GSH-Px activities than the 10-session group
(P<0.05; Figure 2).
3.3. Cerebellum. In the 5- and 30-session HBO2 exposure
groups, increased levels of GSH-Px activities were recorded;
however, due to the wide distribution of the in-group data,
these levels were also not statistically signiﬁcant. Cerebellar
SOD activities, MDA, and PCC values remained nearly un-
c h a n g e da te a c hm e a s u r ep o i n t( P>0.05). Detailed com-
parisons indicated that the GSH-Px activities of the 10- and
15-HBO2 exposure groups were signiﬁcantly less than the 5-
and 30-session groups (P<0.05; Figure 3).
4. Discussion
In the present study, the oxidative potential as well as the
CNS oxygen toxicity risk of daily repetitive HBO2 exposures
over a prolonged period was tested in rat’s brain tissue.
The main two outcomes of this study were that (i) with
regard to lipid and protein oxidation product’s values, HBO2
administrations from a minimum of 5 and up to 40 sessions
caused no oxidative stress in diﬀerent brain tissue regions
of the rats and (ii) antioxidant enzymes SOD and GSH-Px
activities remained also nearly unchanged throughout the
same experimental set.
Earlier works of our institutional study group designated
a clear oxidative eﬀect of acute one-session HBO2 exposures
in rat’s brain cortex tissue [18–20]. These studies indicated
a pressure- [18] and exposure-time- [19] related oxidative
action by measuring lipid peroxidation products in brain
cortex homogenates. The maximal HBO2 exposure time and
pressure in the above-mentioned works were limited with
the maximal approved clinical used limits as 2h and 3atm
[1], respectively; however, the evidenced oxidative eﬀect
began just with the halves of these limits, that is, 1h and
1.5atm. The unchanged levels of the oxidative stress markers
MDA and PCC in the present study appear to be con-
tradictory when compared with the former experiments. On
the other hand, in previous studies it was also seen that theThe Scientiﬁc World Journal 5
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Figure 3: Cerebellar values of oxidation products and antioxidant enzymes activities. C: control group; numbers on the x-axis stand for the
HBO2 session number of the groups. One way ANOVA: 1P<0.001. Bonferroni:
∗P = 0.009 and P = 0.004,
∗∗P = 0.01 and P = 0.004 versus
10- and 15-exposure groups, respectively. Comparisons with the control groups resulted in comparable values.
oxidative eﬀect after a single HBO2 exposure, even at its
maximal approved safe limits of 3atm for 2h, remains no
more than 90min after removing the animals from the hy-
perbaric chamber [20]. As described previously, in the cur-
rentworktheanimalsweresacriﬁced24hafterthelastHBO2
administrations; this may be one explanation for the present
outcome.
When experimental animals were exposed to HBO2 at
supranormal amounts, that is, above 3atm and 2h, the main
outcome was a clear increase in biooxidative products com-
bined by an exhaustion of endogen antioxidants, namely,
settled oxidative stress [29, 30]. Nevertheless, if the HBO2
administration process was set within therapeutically used
and approved limits, the antioxidant levels mostly accom-
pany the rise of oxidation products [18–20, 31, 32]. Diﬀerent
fromthesereportsandsimilartotheiroutcomeforoxidation
products, the current work represents no signiﬁcant changes
for SOD and GSH-Px activities in three diﬀerent regions of
the rat’s brain. Again, the 24h waiting period after the ﬁnal
HBO2 session may be the reason for this ﬁnding.
A more recent work of our team, conducted with the
samerepetitiveHBO2 exposureprocedureofthecurrentone,
resultedinincreasedoxidativestressmarkersandantioxidant
enzymes after 20 and more sessions in rat’s lung tissue [21].
Thediﬀerentnatureoftheresponseoflungandbraintissues,
two main targets of hyperoxic hyperoxia [18, 29], is quite
interesting and needs to be clariﬁed by further research. The
present limited outcome can just be interpreted as a sign for
am o r ee ﬃcient defense system of the CNS than the lung,
or a gradually lessened toxicity of oxygen depending on the
distance from the primarily attacked lung cells to the brain.
In the medical literature, there are former reports about
an adaptive mechanism which protects against further
oxidative damage when HBO2 was administered for more
than a single exposure [33, 34]. Other reports manifested
HBOT as a beneﬁcial preconditioning application in order
to prevent several organs or tissues from following oxidative
injuries [35, 36]. These adaptive and preconditioning actions
triggered by HBO2 treatments may also be responsible for
the underlying mechanisms of the present ﬁndings. The
intracellular antioxidant enzyme heme oxygenase-1 (HO-
1) has mainly been hold responsible for the HBOT-caused
adaptive changes [36, 37]; however, with the limited para-
meters of the present study, we cannot prove whether this6 The Scientiﬁc World Journal
molecule is the key factor for unchanged oxidative stress
markers even after 40 HBO2 exposures or not.
In a previous study conducted in our institution,
increased PCC values and SOD activities were recorded in
rat’slungandbraintissuesaftera10-sessionHBO2 exposure,
each at 2.5atm for 1h daily [32]. The main diﬀerence of the
present study from this one is the time of tissue harvesting;
in the previously mentioned work the animals were sacri-
ﬁced immediately after the last HBO2 treatment but, as em-
phasized previously, in the present one animals were hold for
one day until their brain tissues were collected. This result
obviously designates to a number of biological arrangements
resultinginamoreeﬀectivescavengingactionagainstHBO2-
induced oxidative attack during the 24h resting period after-
wards.
The ﬁrst sign of CNS oxygen toxicity has been described
tobethehyperoxicseizures/convulsions[38]. Aconsiderable
number of experimental works have long been concentrated
on the underlying mechanisms of this reaction [15–17,
39–41]. Interestingly, some of these studies reported that
repeated exposures to HBO2 increased the sensitivity to seiz-
ures with regard to free radical and/or nitric-oxide-depend-
ent mechanisms [42, 43]. However, our present study reveal-
ednosignforanincreasedproductionofHBO2-inducedfree
radical production or subsequent oxidative eﬀects on bio-
molecules with repeated exposures. As a possible reason, it
must be taken into consideration that all of the previously
mentioned studies were conducted at extreme high pressure
varying from 4 to 7atm and were straightly directed to
induce CNS toxicity in order to examine the reasons or
preventive methods; on the other side, the present work is set
at clinically approved pressure/duration ranges, and there-
fore it is not unpredicted to result without any toxicity sign.
Since HBO2 is an important therapeutic approach with
life-saving properties in various conditions and its eﬃcacy
generally depends on repeated exposures for several days
[1], it is of particular importance to deﬁne its molecular
interactions when administered in repetitive manner. Diﬀer-
ent from the previous study which revealed some oxidative
actions in the lung tissue after 20 and more HBO2 sessions
[21], the present work resulted in nonsigniﬁcant changes of
oxidativeandantioxidantsystemmarkersinbraintissuewith
up to 40 consecutive HBO2 exposures. This result may be
interpreted as a sign for (i) a robust defensive mechanism
against the hyperoxic attack, (ii) an adaptive response as
reported in earlier studies [33, 34], and/or (iii) an eﬀective
repair mechanism scavenging the entire injury within the
24h postexposure period in CNS of the rats. Further studies,
concentrated on transcription factors and their target genes
known to be triggered and activated with HBOT may help
to elucidate the exact pathways and molecular interactions
which occur during or after repeated HBO2 administrations.
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